Searchable News & Info From Reliable Online Sources.
- Can food be medicine? A new study tests the idea in heart failure patients
Experts say better food choices can improve long-term quality of life By Kristen Dalli of ConsumerAffairs May 1, 2026 A clinical trial tested whether delivering healthy food helps people recover after heart failure hospitalization. The program was highly feasible, with strong participation and satisfaction among patients. While it didnt reduce hospital visits, patients reported meaningful improvements in quality of life. The idea that food can play a role in medical care has been gaining traction but how well does it actually work in real life? A new clinical trial led by UT Southwestern Medical Center set out to answer that question in people recovering from heart failure, a condition affecting millions of Americans. After leaving the hospital, many patients face a tough transition. Managing medications, following dietary guidelines, and accessing healthy food can all be challenging especially for those experiencing food insecurity. Researchers wanted to know whether directly providing nutritious food could help. Their approach sometimes called food as medicine focused on giving patients the tools and resources to eat better during a critical recovery window. This was designed as a pilot trial to answer a very practical question: Can we actually deliver food-as-medicine interventions to patients in the vulnerable period after a heart failure hospitalization and will patients accept them? researcher Ambarish Pandey, M.D. said in a news release. What we showed is that this approach is not only feasible, but patients also really valued it. How the study worked The trial included 150 patients who had recently been hospitalized for heart failure at two hospitals in Dallas between April 2024 and October 2025. Participants were enrolled within two weeks of discharge and followed for 90 days. They were randomly assigned to one of three groups: one received medically tailored meals designed by dietitians, another received boxes of fresh produce along with recipes, and a third group received standard care with dietary counseling alone. Among those receiving food support, researchers also tested whether tying deliveries to behaviors like attending clinic visits or filling prescriptions made a difference. The study tracked several outcomes, including how consistently food was delivered, how much participants used it, and whether it affected hospital readmissions or emergency department visits. Researchers also measured quality of life using a standardized questionnaire. What the researchers found Overall, the program proved highly workable. More than 90% of food deliveries… [TheTopNews] Read More.7 hours ago - Trump says government gave ‘final’ bailout proposal for Spirit Airli...
Talks with bondholders for a government bailout this week have not yet yielded a deal. [TheTopNews] Read More.7 hours ago - Nationwide May Day protests planned
May Day demonstrations are expected Friday, as organizers call for boycotts of school, work and shopping in protest of Trump's policies. [TheTopNews] Read More.7 hours ago - Why you won’t find Kentucky Derby bets on prediction platformsThe Kentucky Derby takes place Saturday in Louisville. Prediction market platforms like Kalshi and Polymarket are sitting the race out. [TheTopNews] Read More.7 hours ago
- Common IBS treatments may carry hidden long-term risksLarge U.S. study finds small but notable mortality link By Kristen Dalli of ConsumerAffairs May 1, 2026 A large U.S. study found some IBS medications are linked to a higher risk of death over time. Antidepressants and certain antidiarrheal drugs showed the strongest associations. Researchers stress the overall risk remains small and not cause-and-effect. For millions of Americans living with irritable bowel syndrome (IBS), daily symptom management often means relying on medication. But a new large-scale study is raising questions about how safe some of those treatments are over the long haul. Researchers from Cedars-Sinai examined commonly used IBS medications and found that some may be associated with a small but measurable increase in the risk of death. While that might sound alarming, experts emphasize that the overall risk for any one person remains low. Many patients are diagnosed with IBS at a young age and may remain on medications for years, researcher Ali Rezaie, M.D. said in a news release However, most clinical trials of these medications last less than a year, so we know very little about their long-term safety. This study begins to address that gap. How the study was conducted To better understand long-term safety, researchers analyzed nearly two decades of electronic health records from more than 650,000 adults in the United States diagnosed with IBS. This makes it the largest real-world study of its kind. The team compared patients taking different types of IBS treatments, including FDA-approved medications, antidepressants, antispasmodics, and opioid-based antidiarrheal drugs like loperamide and diphenoxylate. Using this large dataset, researchers evaluated how these medications were associated with all-cause mortality over time. Importantly, the study was observational, meaning it looked at patterns in existing data rather than testing medications in a controlled trial. That distinction matters: the findings show associations, not proof that the drugs directly cause harm. What the researchers found The results revealed clear differences between medication types. Long-term use of antidepressants was associated with about a 35% higher risk of death compared to non-use. Meanwhile, two commonly used antidiarrheal drugs loperamide and diphenoxylate were linked to roughly double the risk. On the other hand, several other treatments did not show this association. Antispasmodics and certain FDA-approved IBS medications were not linked to increased mortality risk. Researchers also noted that the increased risk may be tied to higher rates of serious health… [TheTopNews] Read More.7 hours ago
- Trump Says He’s ‘Not Satisfied’ With the Deal Iran Is Offering to End War
President Donald Trump took questions from reporters while departing the White House on Friday and made clear that the negotiations with Iran have yet to result in a deal he is happy with. CNN’s Dana Bash cut from her show to the live feed of Trump, noting the president is “leaving for Florida. He’s on the South Lawn of the White House taking questions on Iran as he leaves. Let’s listen.” “Can you tell us about the new Iranian proposal?” a reporter shouted. Trump replied, “So they want to make a deal, but I don’t — I’m not satisfied with it, so we’ll see what happens. Iran wants to make the deal because they have no military left, essentially. And they want to make a deal, but I’m not satisfied.” Another reporter then asked if Trump will seek congressional approval for the war and he replied, “Because it’s never been sought before. There’s been numerous, many, many times, and nobody’s ever gotten it before. They consider it totally unconstitutional. But we’re always in touch with Congress. But nobody’s ever sought it before, nobody’s asked for it before, it’s never been used before.” “Are you willing to send anybody to Islamabad?” followed up another reporter. “We have great respect for Pakistan and Islamabad and tremendous respect for the Prime Minister and the Field Marshal. And they’re working with us. They continue to work with us, but the trip is a very long one, and we’re doing everything in terms of negotiating right now in terms of the negotiation telephonically. They’ve made strides, but I’m not sure if they ever get there. There’s tremendous discord, there’s tremendous — they’re having a tremendous problem getting along with each other in Iran. The leadership is very disjointed. It’s got two to three groups, maybe four, and it’s a very disjointed leadership. And with that being said, they all want to make a deal, but they’re all messed up,” replied Trump. Watch the clip above via CNN.The post Trump Says He’s ‘Not Satisfied’ With the Deal Iran Is Offering to End War first appeared on Mediaite. [TheTopNews] Read More.7 hours ago
The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.
